Open-label Extension for Phase 3 Clinical Trials of Simufilam
NCT ID: NCT05575076
Last Updated: 2025-05-23
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE3
1081 participants
INTERVENTIONAL
2022-11-07
2025-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease
NCT05026177
Open-Label Extension of the PTI-125-04 Study in Mild-to-Moderate Alzheimer's Disease
NCT05352763
Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease
NCT04994483
Simufilam (PTI-125), 100 mg, for Mild-to-moderate Alzheimer's Disease Patients
NCT04388254
A Study to Evaluate the Efficacy and Safety of Semorinemab in Patients With Prodromal to Mild Alzheimer's Disease
NCT03289143
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We anticipate up to 1600 subjects may enroll in this study. Approximately up to 150 clinical sites in the USA, Canada, South Korea, and Australia will have the option to participate in this collaborative research effort.
For subjects electing to participate, the clinical and laboratory assessments from the Week 76 (REFOCUS-ALZ) or Week 52 (RETHINK-ALZ) End-of-Treatment visit will serve as Baseline Visit assessments for the open-label study on Study Day 1. All subjects will return in 4 weeks and every 12 weeks thereafter for safety assessments. At all post-baseline visits, subjects will report any adverse events since their last visit. In addition to adverse event monitoring, safety will be evaluated at every visit by vital signs, brief examinations, clinical laboratory tests (biochemistry, hematology, and urinalysis) and the Columbia Suicide Severity Rating Scale (C-SSRS). Study drug use since the last visit will be assessed and a new bottle of study drug will be dispensed.
The emerging subject safety assessments will be monitored throughout the study by an independent Data Safety Monitoring Board (DSMB).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Simufilam 100 mg
simufilam 100 mg oral tablet, twice daily
Simufilam
simufilam 100 mg oral tablet, twice daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Simufilam
simufilam 100 mg oral tablet, twice daily
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical presentation continues to be consistent with Alzheimer's disease.
* Availability of a study partner.
Exclusion Criteria
* Evidence of a neurologic condition other than AD that significantly contributes to the subject's dementia.
* Current clinically significant psychiatric diagnosis other than AD.
* Unstable, clinically significant medical condition other than AD.
* Any medical condition that in the opinion of the investigator may affect safety or ability to complete the study.
51 Years
89 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cassava Sciences, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James Kupiec, MD
Role: STUDY_DIRECTOR
Cassava Sciences, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
MDFirst Research
Chandler, Arizona, United States
CCT Research - Gilbert Neurology Partners
Gilbert, Arizona, United States
Xenoscience, Inc.
Phoenix, Arizona, United States
Banner Alzheimer's Institute
Phoenix, Arizona, United States
Banner Sun Health Research Institute
Sun City, Arizona, United States
Advanced Research Center, Inc.
Anaheim, California, United States
North County Neurology Associates
Carlsbad, California, United States
Axiom Research, LLC
Colton, California, United States
ATP Clinical Research, Inc.
Costa Mesa, California, United States
Neuro-Pain Medical Center
Fresno, California, United States
Neurology Center of North Orange County
Fullerton, California, United States
Sun Valley Research Center, Inc.
Imperial, California, United States
Senior Clinical Trials
Laguna Hills, California, United States
Shankle Clinic and Hoag Memorial Hospital Presbyterian
Newport Beach, California, United States
Artemis Institute for Clinical Research
Riverside, California, United States
Pacific Research Network, LLC
San Diego, California, United States
Syrentis Clinical Research
Santa Ana, California, United States
Mountain Neurological Research Center
Basalt, Colorado, United States
Colorado Neurological Research Center, PC
Denver, Colorado, United States
Ki Health Partners, LLC
Stamford, Connecticut, United States
JEM Research Institute
Atlantis, Florida, United States
Neurology Offices of South Florida
Boca Raton, Florida, United States
K2 Medical Research- Ocoee
Clermont, Florida, United States
Arrow Clinical Trials
Daytona Beach, Florida, United States
Brain Matters Research
Delray Beach, Florida, United States
Neuropsychiatric Research Center of Southwest Florida
Fort Myers, Florida, United States
Velocity Clinical Research, Hallandale Beach
Hallandale, Florida, United States
Galiz Research
Hialeah, Florida, United States
Infinity Clinical Research - Sunrise
Hollywood, Florida, United States
Luminous Clinical Research
Homestead, Florida, United States
CNS Healthcare - Jacksonville
Jacksonville, Florida, United States
Charter Research
Lady Lake, Florida, United States
ClinCloud
Maitland, Florida, United States
Merritt Island Medical Research, LLC
Merritt Island, Florida, United States
Central Miami Medical Institute (GMI)
Miami, Florida, United States
Mind Institute at Miami Jewish Health
Miami, Florida, United States
New Horizon Research Center
Miami, Florida, United States
Brainstorm Research
Miami, Florida, United States
South Florida Research Phase I-IV INC
Miami Springs, Florida, United States
Suncoast Clinical Research, Inc.
New Port Richey, Florida, United States
Renstar Medical Research
Ocala, Florida, United States
Health Synergy Clinical Research
Okeechobee, Florida, United States
Clinical Neuroscience Solutions, Inc. dba CNS Healthcare
Orlando, Florida, United States
Medical Research
Port Orange, Florida, United States
Intercoastal Medical Group - Sarasota
Sarasota, Florida, United States
Alzheimer's Research & Treatment Center
Stuart, Florida, United States
Clinical Research of Brandon, LLC (Tampa)
Tampa, Florida, United States
Stedman Clinical Trials
Tampa, Florida, United States
Alzheimer's Research & Treatment Center
Wellington, Florida, United States
Premier Research Institute at Palm Beach Neurology
West Palm Beach, Florida, United States
Charter Research
Winter Park, Florida, United States
Columbus Memory Center, PC
Columbus, Georgia, United States
Accel Research Sites - NeuroStudies
Decatur, Georgia, United States
Velocity Clinical Research - Boise
Meridian, Idaho, United States
Advocate Aurora Health - Advocate Memory Center
Park Ridge, Illinois, United States
Ascension Via Christi Research
Wichita, Kansas, United States
University of Kentucky
Lexington, Kentucky, United States
Neuro Medical Clinic of Central Louisiana, LLC
Alexandria, Louisiana, United States
Neurology Center of New England
Foxborough, Massachusetts, United States
ActivMed Practices & Research, LLC
Methuen, Massachusetts, United States
Boston Center for Memory
Newton, Massachusetts, United States
Boston Neuro Research Center
North Dartmouth, Massachusetts, United States
Headlands Eastern MA LLC
Plymouth, Massachusetts, United States
MedVadis Research
Waltham, Massachusetts, United States
Clinical Research Professionals
Chesterfield, Missouri, United States
CCT Research - Papillion Research Center
Papillion, Nebraska, United States
Patient First MD
Middletown, New Jersey, United States
Advanced Clinical Institute, Inc
Neptune City, New Jersey, United States
Global Medical Institutes, LLC
Princeton, New Jersey, United States
The Cognitive and Research Center of New Jersey (CRCNJ)
Springfield, New Jersey, United States
Advanced Memory Research Institute of NJ
Toms River, New Jersey, United States
Neurology Specialists of Monmouth County
West Long Branch, New Jersey, United States
Albuquerque Neuroscience, Inc
Albuquerque, New Mexico, United States
Albany Medical Center
Albany, New York, United States
Neurological Associates of Albany
Albany, New York, United States
Dent Neurologic Institute
Amherst, New York, United States
Integrative Clinical Trials, LLC
Brooklyn, New York, United States
SPRI Clinical Trials Brooklyn
Brooklyn, New York, United States
Velocity Clinical Research, Formerly Clarity Clinical Research
East Syracuse, New York, United States
Parker Jewish Institute for Health Care & Rehabilitation
New Hyde Park, New York, United States
Mid Hudson Medical Research
New Windsor, New York, United States
NY Neurology Associates
New York, New York, United States
University of Rochester Medical Center - Alzheimer's Disease Care, Research and Education Program
Rochester, New York, United States
Richmond Behavioral Associates
Staten Island, New York, United States
Richmond Behavioral Associates
Staten Island, New York, United States
Triad Clinical Trials, LLC
Greensboro, North Carolina, United States
Alzheimer's Memory Center
Matthew, North Carolina, United States
Accellacare Research of Winston-Salem
Winston-Salem, North Carolina, United States
Insight Clinical Trials LLC
Beachwood, Ohio, United States
NeuroScience Research Center, LLC
Canton, Ohio, United States
Dayton Center for Neurological Disorders
Centerville, Ohio, United States
the Ohio State University
Columbus, Ohio, United States
Neurology Diagnostics
Dayton, Ohio, United States
Neuro-Behavioral Clinical Research
North Canton, Ohio, United States
Summit Research Network, LLC
Portland, Oregon, United States
Center for Cognitive Health - Portland
Portland, Oregon, United States
Keystone Clinical Studies, LLC
Plymouth Meeting, Pennsylvania, United States
Rhode Island Mood & Memory Research Institute
East Providence, Rhode Island, United States
Palmetto Clinical Research
Summerville, South Carolina, United States
Senior Adults Specialty Research, Inc
Austin, Texas, United States
Texas Neurology, PA
Dallas, Texas, United States
Baylor Scott & White Research Institute
Dallas, Texas, United States
Mt. Olympus Medical Research, LLC
Katy, Texas, United States
Grayline Research Center
Wichita Falls, Texas, United States
Re:Cognition Health
Fairfax, Virginia, United States
Northwest Clinical Research Center
Bellevue, Washington, United States
Memory and Brain Wellness Center at Harborview
Seattle, Washington, United States
KaRa Institute of Neurological Diseases Pty. Ltd.
Macquarie Park, New South Wales, Australia
The University of Queensland
Herston, Queensland, Australia
Delmont Consulting Suites
Glen Iris, Victoria, Australia
Austin Health
Heidelberg, Victoria, Australia
The Alfred Hospital
Melbourne, Victoria, Australia
Eastern Health
Melbourne, Victoria, Australia
Alzheimer's Research Australia
Nedlands, Western Australia, Australia
OCT Research ULC DBA Okanagan Clinical Trials
Kelowna, British Columbia, Canada
Dr. George Dumont University Hospital Centre
Moncton, New Brunswick, Canada
True North Clinical Research - Halifax/Nova Scotia
Halifax, Nova Scotia, Canada
True North Clinical Research - New Minas
New Minas, Nova Scotia, Canada
St. Joseph's Health Care London
London, Ontario, Canada
Ottawa Memory Clinic
Ottawa, Ontario, Canada
Kawartha Centre - Redefining Healthy Aging
Peterborough, Ontario, Canada
Toronto Memory Program
Toronto, Ontario, Canada
The Centre for Memory and Aging
Toronto, Ontario, Canada
Q & T Research
Sherbrooke, Quebec, Canada
Diex Research - Sherbrooke
Sherbrooke, Quebec, Canada
Alpha Recherche Clinique
Québec, , Canada
Barbara Diaz Hernandez Md Research, Inc.
San Juan, PR, Puerto Rico
Santa Cruz Behavioral PSC
Bayamón, , Puerto Rico
Inspira Clinical Research
San Juan, , Puerto Rico
Kyungpook National University Chilgok Hospital
Daegu, Buk-gu, South Korea
Chonnam National University Hospital
Gwangju, Dong-gu, South Korea
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
Gachon University Gil Hospital
Namyangju, Incheon, South Korea
Inha Unviersity Medical Center
Incheon, Jung-gu, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PTI-125-10
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.